NEW INOTROPIC AGENTS FOR THE TREATMENT OF HEART FAILURE

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$134,076.00
Award Year:
2002
Program:
STTR
Phase:
Phase I
Contract:
1R41HL067498-01A1
Award Id:
60295
Agency Tracking Number:
HL067498
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
RELIABLE BIOPHARMACEUTICAL CORP., BOX 2517, 1945 WALTON RD, ST. LOUIS, MO, 63114
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
BRUCE LIANG
() -
Business Contact:
JOSEPH TOCE
(314) 429-7700
Research Institution:
UNIVERSITY OF CONNECTICUT HEALTH CENTER

UNIVERSITY OF CONNECTICUT HEALTH CENTER
FARMINGTON, CT, 06030

Nonprofit college or university
Abstract
DESCRIPTION (provided by applicant): The goal of the project is to develop new positive inotropes, represented by specifically modified AMP molecules. All of the currently available positive inotropic agents have significant adverse effects with digitalis being the only orally available positive inotrope. ATP causes a pronounced positive inotropic effect. Receptors for ATP, known as P2 purinergic receptor, has been shown to mediate its positive inotropic effect. However, agonists acting at this cardiac P2 receptor with enhanced efficacy, potency and selectivity, are lacking. Preliminary data suggest that certain specific modifications of the AMP molecule will confer positive inotropic activity and selectivity vs. the vascular P2 receptor. Adult rat ventricular myocytes and intact heart model have been developed to determine the affinity and efficacy of new agents at the myocyte P2 receptor and their effects on the various functional parameters in the intact heart. The overall objective of the study is to use these cardiac models to test these specifically modified AMP molecules at the cardiac P2 receptor. New chemical structures will be correlated with the affinity and the positive inotropic activity and cardiac vs. vascular P2 receptor selectivity. The effects of these compounds on the heart rate and blood pressure in conscious rats will also be determined. The studies may lead to potentially useful new positive inotropic agents for the treatment of heart failure.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government